TABLE 3.
MICs of the four novel oxazolidinones for the Mtb clinical isolates with different MICs of linezolid.
| Linezolid | No. of isolates with different MICs (μg/ml) | ||||
|
|
|
||||
| MIC (μg/ml) | No. of isolates | Contezolid | Tedizolid | Sutezolid | Delpazolid |
| ≤ 0.0625 | 3 | ≤ 0.0625 (2) 0.25 (1) |
≤ 0.0625 (3) | ≤ 0.0625 (3) | ≤ 0.0625 (1) 0.25 (1) 1 (1) |
| 0.125 | 10 | ≤ 0.0625 (3) 0.125 (2) 0.25 (4) 0.5 (1) |
≤ 0.0625 (8) 0.125 (1) 0.5 (1) |
≤ 0.0625 (10) | 0.25 (5) 0.5 (4) 1 (1) |
| 0.25 | 28 | ≤ 0.0625 (6) 0.125 (1) 0.25 (4) 0.5 (17) |
≤ 0.0625 (11) 0.125 (6) 0.25 (8) 0.5 (2) 1 (1) |
≤ 0.0625 (26) 0.125 (2) |
0.25 (2) 0.5 (8) 1 (16) 2 (2) |
| 0.5 | 26 | 0.125 (1) 0.5 (22) 1 (3) |
0.125 (11) 0.25 (12) 0.5 (3) |
≤ 0.0625 (25) 0.25 (1) |
0.5 (4) 1 (7) 2 (14) 4 (1) |
| 1 | 2 | 0.5 (2) | 0.125 (2) | ≤ 0.0625 (2) | 1 (2) |